Dr Matthias Leuenberger

Matthias Leuenberger (*1965, Swiss) studied law at the University of Bern, where he also obtained his doctorate. He worked at the Boston Consulting Group in Zurich and Tokyo for nine years before joining Novartis in Basel in 2004. He held various management positions there, most recently as country president for Switzerland from 2014 to the end of 2024. Matthias Leuenberger was also president of scienceindustries from 2018 until the end of May of 2025, and is Vice President of economiesuisse. His many years of experience in various leading positions in the pharmaceutical industry, among others, make him an ideal addition to the ETH Board. Leuenberger took office on the ETH Board on 1 January 2026 as the successor to Susan Gasser, whose term of office expired at the end of 2025.